ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 726310 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 726310; 2) Community: the network communities that were significantly associated with the response to NSC 726310; 3) Molecule: the relationships between components within communities and NSC 726310; 4) MDR: the compounds that were significantly associated with the NSC 726310.

NSC Compound Enrichment Correlation
NSC 746513 5-Triazol-2-yl-methyl-2-[2?,(2??-chlorophenyl)-thiazolidin-4?-one-3?-yl]-1,3,4-oxadiazole 0.0385203205529756 -0.15138594
NSC 748404 Null 0.0385203205529756 -0.26930143
NSC 748904 [(20S)-20-(N,N-dimethylamino)-5a-preg-3a-aminal], N-formylchonemorphine 0.0385203205529756 -0.30301512
NSC 752464 methyl 2-((S,3Z)-6-((E)-1-hydroxy-3-phenylallylidene)-5-oxocyclohex-3-enyl)acetate 0.0385203205529756 0.00027551336
NSC 757113 METHOTREXATE(+/-) 0.0385203205529756 -0.23873642
NSC 760181 9-(3-fluorobenzyl)-7-(3-fluorobenzyloxy)-2-(4-fluorobenzyl)-1-methyl-9H-beta-carbolinium bromide 0.0385203205529756 -0.048598393
NSC 88915 Null 0.0385203205529756 -0.037541676
NSC 106969 CENTAUREIDIN 0.0385203205529759 -0.14177286
NSC 107124 Camptothecin Derivative 0.0385203205529759 0.084578863
NSC 236580 .beta.-Alanine, N-[N-[N-[N-[1-(D-2-hydroxy-4-methyl-1-oxopentyl)-L-prolyl]-L-isoleucyl]-N-methyl-L-valyl]-N-methyl-L-alanyl]-, .rho.-lactone 0.0385203205529759 -0.16369696
Total:74  Current:56    [First] [Prev] [Next] [Last]